Dynavax to Report Second Quarter 2023 Financial Results and Host Conference Call on August 3, 2023

EMERYVILLE, Calif., July 20, 2023 /PRNewswire/ — Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company developing and commercializing innovative vaccines, will report second quarter 2023 financial results on Thursday, August 3, 2023, after the U.S….

Click here to view original post


ADVERTISEMENT — Advertise With Biotech Networks